BIOCRYST PHARMACEUTICALS, INC. Inventory
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Inventory of $6.06 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-05
- 2026-06-30: Inventory, Net $6.06M.
- 2026-03-31: Inventory, Net $5.99M.
- 2025-12-31: Inventory, Net $5.40M.
- 2025-09-30: Inventory, Net $5.23M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $6.06M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $5.99M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $5.40M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $5.23M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $5.04M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $6.87M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $8.09M 10-K · filed 2026-02-26 | $31.27M 10-K · filed 2025-02-25 |
| 2024-09-30 | $7.56M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $4.45M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $29.78M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $28.68M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $29.63M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $27.03M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $27.47M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $27.53M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $27.02M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $23.38M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $16.14M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $15.79M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $13.66M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $9.85M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $5.11M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $7.04M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $6.24M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $5.23M 10-Q · filed 2020-08-07 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | |
| 2019-09-30 | $1.78M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $600.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.65M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $821.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $221.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.00K 10-Q · filed 2018-05-09 | |
| 2017-06-30 | $1.30M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $655.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $500.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $2.23M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $1.95M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $1.95M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.61M 10-K · filed 2017-02-27 | |
| 2015-06-30 | $1.31M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.21M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $683.00K 10-K · filed 2016-02-26 | |
| 2012-09-30 | $263.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $263.00K 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $263.00K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $263.00K 10-K · filed 2013-03-11 | |
| 2011-09-30 | $898.00K 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $898.00K 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $898.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |